bexarotene gel

bexarotene gel information and resources from the National Cancer Institute

Targretin

For the topical treatment of cutaneous manifestations of cutaneous T-cell lymphoma in patients who are refractory to at least one prior systemic therapy.

Ligand Pharmaceuticals Jun 28 2000

bexarotene gel -->

Home | About | Search topics | Cancers | Treatment | Medications
Onconews provides free news and resources on cancer-related topics.

Copyright onconews.org 2005-2006.
All Rights Reserved.
Google
 
Web onconews.org